Beximco Proposes Five-Point Plan to Safeguard Operations and Jobs

Industry: Healthcare & Pharma
Company: Beximco Group
Company Intelligence Tag: Business Insights

Beximco Group has submitted a five-point proposal to the government to ensure the continuity of its operations, particularly in the export-oriented garment and textile sectors, while safeguarding the jobs of 40,000 employees. The proposal includes transferring all outstanding dues into an interest-free block account, with a 10-year repayment period and a two-year moratorium. The group is also seeking the establishment of back-to-back letters of credit for exports, bill discounting facilities, and a packing credit facility. Beximco is concerned about meeting worker wages for September, totaling Tk65 crore, and has requested that this amount be deducted from received export proceeds. The group emphasized the urgency of its situation, stating that without additional credit facilities since May 2024, they face significant operational challenges, including potential downsizing or reduced expenditures. The proposal outlines expectations for business recovery by January 2025, provided shipments resume immediately. Additionally, recent events have led to the freezing of personal accounts of key stakeholders, further complicating the financial landscape for Beximco. The group expressed that continued cash deficits could jeopardize their customer base permanently if unresolved.

Source for more details:

Related News

Vice Chairman of Square Pharma to Acquire 15 Lakh Shares

March 13, 2025

Ratna Patra, vice chairman and sponsor of Square Pharmaceuticals, announced her plan to purchase 15 lakh shares worth approximately Tk 33 crore at the current market price. The purchase will take place within the next 30 working days through both public and block markets on the Dhaka Stock Exchange (DSE).

NBR Cuts Advance Tax on Cancer Drug Materials to 2%

March 12, 2025

The National Board of Revenue (NBR) has exempted the advance tax (AT) on the import of raw materials for cancer drug manufacturing, aiming to reduce production costs and drug prices. Previously, a 5% AT was imposed, but it has now been reduced to 2% or eliminated altogether.

Square Pharma Chairman to Buy 15 Lakh Shares for Tk 32 Crore

March 11, 2025

Samuel S Chowdhury, chairman of Square Pharmaceuticals, plans to buy 15 lakh shares worth over Tk 32 crore within 30 working days through the Dhaka Stock Exchange (DSE). As of November 30, 2023, he held a 9.32% stake, which will rise to 9.49% after the purchase.

Pharma Exports Grow 7.1% in Eight Months of FY24-25

March 10, 2025

Bangladesh's pharmaceutical exports saw steady growth in the first eight months of FY24-25, earning $145.46 million, a 7.1% increase from $135.81 million in the same period of the previous year. Growth was driven by rising demand in developed markets like the US, Australia, and Europe.

Govt Provides Tk 525.46 Crore to Beximco for Worker Dues

March 8, 2025

The government has provided Tk 525.46 crore to Beximco Group to settle dues for workers and officials of 14 closed textile and garment units. The funds, allocated by the finance division, will be disbursed as a loan, which Beximco must repay later.

SC Allows Govt-Approved Directors to Rejoin Beximco Firms

March 5, 2025

The Appellate Division of the Supreme Court has allowed independent directors appointed by the Bangladesh Securities and Exchange Commission (BSEC) to resume duties at Beximco, Beximco Pharmaceuticals, and Shinepukur Ceramics.

Related News

Vice Chairman of Square Pharma to Acquire 15 Lakh Shares

March 13, 2025

Ratna Patra, vice chairman and sponsor of Square Pharmaceuticals, announced her plan to purchase 15 lakh shares worth approximately Tk 33 crore at the current market price. The purchase will take place within the next 30 working days through both public and block markets on the Dhaka Stock Exchange (DSE).

NBR Cuts Advance Tax on Cancer Drug Materials to 2%

March 12, 2025

The National Board of Revenue (NBR) has exempted the advance tax (AT) on the import of raw materials for cancer drug manufacturing, aiming to reduce production costs and drug prices. Previously, a 5% AT was imposed, but it has now been reduced to 2% or eliminated altogether.

Square Pharma Chairman to Buy 15 Lakh Shares for Tk 32 Crore

March 11, 2025

Samuel S Chowdhury, chairman of Square Pharmaceuticals, plans to buy 15 lakh shares worth over Tk 32 crore within 30 working days through the Dhaka Stock Exchange (DSE). As of November 30, 2023, he held a 9.32% stake, which will rise to 9.49% after the purchase.

Pharma Exports Grow 7.1% in Eight Months of FY24-25

March 10, 2025

Bangladesh's pharmaceutical exports saw steady growth in the first eight months of FY24-25, earning $145.46 million, a 7.1% increase from $135.81 million in the same period of the previous year. Growth was driven by rising demand in developed markets like the US, Australia, and Europe.

Govt Provides Tk 525.46 Crore to Beximco for Worker Dues

March 8, 2025

The government has provided Tk 525.46 crore to Beximco Group to settle dues for workers and officials of 14 closed textile and garment units. The funds, allocated by the finance division, will be disbursed as a loan, which Beximco must repay later.

SC Allows Govt-Approved Directors to Rejoin Beximco Firms

March 5, 2025

The Appellate Division of the Supreme Court has allowed independent directors appointed by the Bangladesh Securities and Exchange Commission (BSEC) to resume duties at Beximco, Beximco Pharmaceuticals, and Shinepukur Ceramics.

BUSINESSMONITOR

Connect with


Dont Have Account? Please register Here